Valuation: Yuhan Corporation

Capitalization 7,712B 5.63B 4.89B 4.6B 4.18B 7.7B 486B 8.63B 53.99B 20.87B 222B 21.12B 20.67B 814B P/E ratio 2025 *
66.9x
P/E ratio 2026 * 45x
Enterprise value 7.66B 5.59M 4.85M 4.57M 4.15M 7.65M 483M 8.57M 53.63M 20.73M 221M 20.98M 20.54M 809M EV / Sales 2025 *
3.36x
EV / Sales 2026 * 3.06x
Free-Float
67.64%
Yield 2025 *
0.47%
Yield 2026 * 0.47%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.96%
1 week-3.26%
Current month-0.58%
1 month-2.35%
3 months-18.02%
6 months-11.37%
Current year-13.22%
More quotes
1 week 103,500
Extreme 103500
108,800
1 month 102,300
Extreme 102300
110,900
Current year 100,400
Extreme 100400
140,700
1 year 75,900
Extreme 75900
166,900
3 years 47,571.43
Extreme 47571.4286
166,900
5 years 41,464.2
Extreme 41464.2047
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
More quotes
Manager TitleAgeSince
Chief Executive Officer 70 18/03/2021
Director of Finance/CFO 57 -
President 66 14/03/2024
Director TitleAgeSince
Chairman 73 18/03/2021
Director/Board Member 70 19/03/2015
Director/Board Member 60 29/02/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.96%-3.26%+37.17%+110.16% 5.68B
-2.14%-5.43%-35.15%-30.64% 56.17B
-0.38%-0.32%-7.39%-15.13% 8.95B
+0.02%-1.36%+5.67%+20.34% 6.54B
-0.11%-2.36%+18.34%+30.75% 5.2B
-2.94%-10.91%+52.80%+0.53% 3.4B
+1.96%-0.57%+23.63%+21.98% 2.02B
-1.76%-3.73%-2.49%+17.17% 2.01B
+0.33%-3.58%-59.43%-9.96% 1.76B
+0.97%+2.67%-18.06%-27.14% 1.73B
Average -0.50%-3.00%+1.51%+11.81% 9.35B
Weighted average by Cap. -1.46%-4.25%-17.22%-9.85%
See all sector performances

Financials

2025 *2026 *
Net sales 2,280B 1.66B 1.44B 1.36B 1.24B 2.28B 144B 2.55B 15.96B 6.17B 65.79B 6.24B 6.11B 241B 2,462B 1.8B 1.56B 1.47B 1.33B 2.46B 155B 2.76B 17.23B 6.66B 71.02B 6.74B 6.6B 260B
Net income 117B 85.68M 74.38M 70M 63.59M 117M 7.4B 131M 822M 318M 3.39B 321M 315M 12.39B 175B 128M 111M 104M 94.81M 175M 11.04B 196M 1.23B 474M 5.05B 479M 469M 18.47B
Net Debt -51.05B -37.26M -32.35M -30.44M -27.65M -50.98M -3.22B -57.13M -357M -138M -1.47B -140M -137M -5.39B -174B -127M -110M -104M -94.08M -173M -10.95B -194M -1.22B -470M -5.01B -476M -465M -18.33B
More financial data * Estimated data
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical segment is engaged in the production and sale of non-prescription drugs including anti-inflammatory drugs, as well as prescription drugs such as drugs for hepatitis, diabetes, and hypertension. The Life and Health segment is involved in the production and sale of household goods and animal healthcare (AHC) products, including bleach, antibacterial agents. The Overseas Business segment supplies raw drugs to domestic and overseas markets. The Company also sells licenses. The Company distributes its products in domestic and overseas markets such as Europe, Asia and United States.
Employees
2,038
Calendar
More about the company
Date Price Change Volume
18/06/25 103,700.00 -0.96% 274,059
17/06/25 104,700.00 -1.51% 351,209
16/06/25 106,300.00 -0.19% 269,720
13/06/25 106,500.00 -1.75% 467,882
12/06/25 108,400.00 +1.12% 374,512

End-of-day quote Korea S.E., June 17, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
103,700.00KRW
Average target price
144,266.67KRW
Spread / Average Target
+39.12%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A000100 Stock